Personalised medicine is transforming the way disease is prevented, treated and managed. This has been coupled with an advance in telehealth technology, allowing patients to monitor their own symptoms on portable electronic devices or mobile phones.
European Respiratory Society: Personalised medication and telehealth are transforming the way disease is prevented, treated and managed.
Share this post
Latest News posts
NHS: COVID-19. What if I’ve already got respiratory condition?
November 13, 2020
British Medical Journal Patient Leaflets
October 21, 2020
Vitamin D and COVID-19
October 16, 2020
The Host, its Microbiome and their Aspergillosis.
August 13, 2020
COVID-19 and Lung Disease
June 30, 2020
Fungal spore and air quality forecasts
June 8, 2020
The New York Times on the dangers of mould
June 7, 2020
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video